News
Martech business tapping into data security and metaverse tailwinds
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In May, Altor Capital’s Benjamin Harrison selected XPON Technologies as one of his favourite stocks, pointing to the company’s high-growth phase, growing…
Industry tailwinds spur bioplastics manufacturer into top line growth
Investing in biotech has become an increasingly attractive proposition for venture capitalists, but the sector can be hard to navigate – so we’ve enlisted one of Australia’s foremost experts in the field to share his thoughts for those in, or considering buying into, the sector.
Why now is an excellent time to invest: Leading biotech investor
Investing in biotech has become an increasingly attractive proposition for venture capitalists, but the sector can be hard to navigate – so we’ve enlisted one of Australia’s foremost experts in the field to share his thoughts for those in, or considering buying into, the sector.
Note from the MD: RBA under pressure amid global frenzy of rate hikes
Central banks around the world are embarking on a frenzy of rate hikes as they try to rein in inflation. The IMF says 75 central banks have raised interest rates in the past year, moving almost four times each on average – including Canada, which last Wednesday surprised global markets with a 100 basis-point increase, the largest by any G7 economy since 1998.
$1 trillion baby: How SaaS rose from traditional software’s ashes
The global market for SaaS (software as a service) has been forecast to hit A$1 trillion in the next six years – and a number of Australian businesses are well-positioned to ride the wave.
Enterprising pub offers bitter-sweet deal amid global food crisis
With Ukraine and Russia producing 80% of global exports of sunflower seed oil, supplies have dwindled in recent months, leading to a cooking oil shortage and supermarket restrictions throughout Europe – but one German pub has found a solution.
Wellnex signs JV to enter $37 billion medicinal cannabis markets
Australian health and wellness brands company Wellnex Life will bring registered medicinal cannabis and hemp-based products to domestic and international markets, via a newly formed joint venture with OneLife Botanicals.
FDA win: Cancer drug granted market exclusivity for blood cancer
The US Food and Drug Administration has granted ‘orphan drug designation’ to PTX-100 for the treatment of peripheral T-cell lymphomas, paving the way for Prescient Therapeutics to lock in years of market exclusivity.
Non-traditional’ telco Superloop looking to take on the incumbents
Australian share markets lost $74 billion in February when Russia invaded Ukraine, leaving many strong companies lost or forgotten in the flurry of the sell-off.
Note from the MD: Investors advised to prepare for 1970s volatility levels
Australia’s labour shortage is becoming a real crisis. Businesses are struggling to fill 300,000 jobs, says the National Skills Commission, while the ABS puts combined private and public sector vacancies at 480,000 – 111% higher than in February 2020, prior to the pandemic.
550 cash-burner and zombie stocks on ASX: Ex-Thorney fundie
No fewer than 374 ‘cash burners’ and 180 ‘zombies’ can be found lurking on the ASX, a former Thorney Investment Group fund manager has revealed – representing a significant opportunity for investors.
‘Zero risk investment’: Penny-wise Aussies turning a nice dollar
It’s the ATM coin trick that an increasing number of young Australians are using to create profits out of thin air – but not everyone is caught up in the magic of the new ‘coin noodling’ craze.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
Receive the latest news and media directly to your inbox
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.